NYSE:LCTX | Free Cash Flow | Lineage Cell Therapeutics, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2009-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$8.08M$55,000.00-$8.13M
2025-12-31-$4.88M$399,000.00-$5.28M-620.09%
2025-03-31-$4.89M$97,000.00-$4.98M
2024-12-31-$6.35M$365,000.00-$6.71M
2024-03-31-$5.78M$38,000.00-$5.82M
2023-12-31-$6.02M$91,000.00-$6.11M
2023-03-31-$11.24M$188,000.00-$11.43M
2022-12-31-$8.3M-$16,000.00-$8.32M
2022-03-31$21.9M$46,000.00$21.86M
2021-12-31-$5.87M$146,000.00-$6.02M
2021-03-31-$7.42M$11,000.00-$7.44M
2020-12-31-$5.64M$24,000.00-$5.67M-278.79%
2020-03-31-$5.03M$10,000.00-$5.04M
2019-12-31-$5.52M$7,000.00-$5.53M
2019-03-31-$9.31M$169,000.00-$9.48M-24.12%
2018-12-31-$5.81M$157,000.00-$5.97M
2018-03-31-$10.34M$198,000.00-$10.54M
2017-12-31-$5.68M$396,000.00-$6.07M
2017-03-31-$8.1M$215,000.00-$8.31M-16.87%
2016-12-31-$8.85M
2016-03-31-$14.31M$583,000.00-$14.9M
2015-12-31-$13.95M$727,000.00-$14.67M
2015-03-31-$9.07M$77,000.00-$9.15M
2014-12-31-$9.11M-$14,000.00-$9.12M
2014-03-31-$10.36M$231,921.00-$10.59M
2013-12-31-$8.63M$300,958.00-$8.93M
2013-03-31-$7.02M$496,128.00-$7.52M
2012-12-31-$5M$195,675.00-$5.19M
2012-03-31-$5.72M$116,603.00-$5.83M
2011-12-31-$3.85M$179,757.00-$4.03M
2011-03-31-$3.36M$295,785.00-$3.65M
2010-12-31-$2.78M$54,324.00-$2.83M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$18.92M$522,000.00-$19.44M
2024-12-31-$23.09M$565,000.00-$23.66M
2023-12-31-$28.57M$674,000.00-$29.24M
2022-12-31$1.06M$413,000.00$646,000.00
2021-12-31-$23.56M$340,000.00-$23.9M
2020-12-31-$19.75M$64,000.00-$19.82M
2019-12-31-$31.95M$440,000.00-$32.39M
2018-12-31-$30.88M$556,000.00-$31.44M
2017-12-31-$30.52M$1.33M-$31.84M
2016-12-31-$42.33M$2.25M-$44.57M-132.77%
2015-12-31-$44.54M$1.24M-$45.79M
2014-12-31-$38.85M$483,000.00-$39.34M
2013-12-31-$29.51M$2.28M-$31.79M
2012-12-31-$19.68M$400,810.00-$20.08M
2011-12-31-$13.59M$960,281.00-$14.55M
2010-12-31-$7.73M$220,771.00-$7.95M
2009-12-31-$4.26M$61,276.00-$4.32M